🔍 Rechercher dans les archives
CAS Connections Brings Trusted Scientific Data and AI to Leading R&D Platforms
COLUMBUS, Ohio, June 3, 2026 — CAS, a division of the American Chemical Society specializing in scientific knowledge management, today announced CAS...
Frankie Meyer: Gravestones can be an important part of family research
Gravestone observations are an essential aspect of family research....
Frankie Meyer: Gravestones can be important part of family research
Gravestone observations are an essential aspect of family research....
VA clinical trial on psychedelic-assisted therapy gives Missouri lawmakers hope
Missouri state Rep. Dave Griffith has spent the last five years digging into research on how psychedelic-assisted therapy has helped veterans struggli...
US robots gets trained for lunar missions with digital twins, VR tech
US researchers use digital twins and VR to train lunar robots that could help astronauts build and explore the Moon....
A science powerhouse bets on genetic therapy to beat brain disorders
The Allen Institute in Seattle says scientists have now learned enough about how the brain works to start fixing it when it breaks....
MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b ...
Phase 1b INFLO-1 study data readout anticipated in Q3 2026...
MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b ...
Phase 1b INFLO-1 study data readout anticipated in Q3 2026...
MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b ...
Phase 1b INFLO-1 study data readout anticipated in Q3 2026...
MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial for Nintedanib DPI in Patients with IPF
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company focuse...
Inside the $23M comeback of Jackson's McNair-Davis Planetarium
Nine years after closing, Jackson's planetarium is nearing reopening with new exhibits, immersive technology and a mission to serve the entire state....
Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence ...
Expands availability of Nociscan in the greater Los Angeles area with leading neuroscience groupAdds to growing body of real-world evidence with study...
KBR Mission Technology Solutions Awarded $8 Billion Antarctic Science and Engineering Support ...
HOUSTON, June 03, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced today its Mission Technology Solutions business has been awarded an $8 billion ce...
KBR Mission Technology Solutions Awarded $8 Billion Antarctic Science and Engineering Support ...
HOUSTON, June 03, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced today its Mission Technology Solutions business has been awarded an $8 billion ce...
Scientists May Have Found a Way to Detect a Third Type of Magnetism
The third type of magnetism could prove the most useful of all—if researchers can identify the materials that exhibit it....
Amazon rainforest emits new stress-defense molecules during El Niño drought
The Amazon rainforest responded to the most severe drought ever recorded in the basin with an unexpected defense mechanism. Researchers at the Max Pla...
Agenus Announces Virtual 2026 Annual Shareholders Meeting
LEXINGTON, Mass.--(BUSINESS WIRE)---- $AGEN #AGEN--Agenus Inc. (“Agenus”) (NASDAQ: AGEN), a leader in immuno-oncology innovation, today announced ...
US Ambassador to Canada Shares '51st State' Post
Canada got another not-so-subtle jab from Washington on Monday, courtesy of the top American diplomat in Ottawa. US Ambassador Pete Hoekstra shared a ...
Cross-Reactive T Cells Could Point to Broad Vaccines or Treatments for Measles, Nipah Virus
Scientists identified "cross-reactive" T cells that can recognize different paramyxovirus pathogens, which may point to the development of vaccines an...
Fulcrum Halts Development of SCD Candidate Pociredir, Sets Strategic Review
The FDA's concerns, which the agency raised with Fulcrum executives at a recent end-of-phase meeting, stemmed from an unexpectedly high rate of second...